The Future of the Consulting Room Lies at Home

Patients are sitting in a heavily occupied waiting room on white chairs.

Not more frequent hospital visits for check-ups, but more measuring, monitoring, and information from home. In the Flagship Consultation Room 2030, doctors, engineers, designers, economists, and behavioural scientists are exploring how technology can enable part of healthcare to be delivered at home. This not only saves significant time for both healthcare providers and patients but also allows for more personalised care.

The pressure on healthcare continues to grow, driven by aging populations and a rising shortage of staff. Technology can alleviate this strain, yet many digital tools fail to make their way into everyday practice. As a result, patients do not always receive care tailored to their needs and often make unnecessary trips to the hospital—adding to the burden on healthcare providers. Shifting part of the care from hospitals to the home offers a solution.

In the Flagship Consultation Room 2030, researchers are investigating how the future of healthcare could look with the help of digital tools and smart use of data.

Joke Hendriks looks towards the camera.

Professor J.M. (Joke) Hendriks, vascular surgeon, head of the surgery department, and member of the Board of Directors at Erasmus MC. 

What are you researching in the Flagship Consultation Room 2030?

'We are exploring the possibilities of moving care that has traditionally been provided in hospitals—partially or entirely—to the home. Hence the subtitle: Continuity of Care from Hospital to Home. Our focus is on the consulting room, as it serves as the gateway to healthcare. From there, we hope to initiate a transition in how care is delivered. In the Flagship, we are examining various care pathways and patient groups to see if we can optimise home-based care using digital means, such as monitoring apps or diagnostic tools.'

What is the greatest added value of shifting care to the home?

'It benefits both the care provider and the recipient. For example, consider time savings. Currently, patients visit the hospital one or more times a year for check-ups, even when their health or symptoms haven't changed. If we already know this through digital monitoring tools, a hospital visit may not be necessary. A doctor can receive this data via an app, keeping them informed of the patient's medical situation. Additionally, patients conducting their own measurements gain more control over their health.'

Why is it important to collaborate with TU Delft and Erasmus University in this effort?

'TU Delft brings extensive expertise in technology and design. Erasmus University offers a more reflective perspective on what we are doing: What challenges do patients and healthcare providers face? What works and what doesn't? And what is needed for structural change? They also explore financing models to make certain solutions attractive to health insurers.

The combination of these expertises truly helps us move forward. Not only because of knowledge sharing and access to a broad network, but also because each of us approaches the problem differently. For instance, a doctor prefers a quick, concrete solution to an immediate problem, while a designer thinks more conceptually and looks further ahead. I had to adjust to this at first. But these diverse perspectives help us look beyond daily routines and think about the steps we need to take to achieve our goals.'

A patient has a conversation with a doctor during a consultation in the hospital

More care from home also demands more from the patient. How do you keep healthcare accessible to everyone?

'We know that some patients find fewer hospital visits and more control over their medical condition very pleasant. You see this trend in society as well, for example with the rise of smartwatches that allow people to monitor their health at home. At the same time, we recognise that not everyone is equally digitally literate, and some people prefer in-person appointments. However, if we manage to shift part of the care to the home, it actually creates more room for those who prefer face-to-face consultations with a doctor.

It's a misconception to think that we will replace everything with technology and that everyone will have to use apps. We need to offer solutions for a broad group. Ultimately, the doctor and patient remain jointly responsible for the care trajectory. The difference is that the structure of this care will look different, giving patients more control. I see this as a positive development. I believe we should encourage people to take more ownership of their health, including in terms of prevention. It's up to doctors to provide information and deliver the right care when needed.'

What are the obstacles to bringing about a transition in healthcare?

'We face several challenges. One is financing. If you add something to the healthcare system, something else must be removed. We notice that insurers and governments are hesitant to fund the digitisation of healthcare. Additionally, some initiatives run into legal and regulatory hurdles, particularly regarding privacy. For example, if technology is classified as a medical device, the EU's MDR regulation has applied since 2021 to ensure safety and quality. While this is important, the downside is that it costs a lot of money and time to demonstrate compliance with all the strict requirements and obtain certification. Furthermore, it can be difficult to get certain research questions approved by medical ethics committees (METC). As a result, it doesn't always succeed in implementing something in daily practice, or it takes a long time. And if something takes too long, there's a risk that the technology or tool becomes outdated.'

What do you hope the Flagship will ultimately achieve?

'I would find it wonderful if we could continue this in the long term, for example in the form of a centre of expertise. Other countries are also struggling with healthcare challenges and working on improvements, but what we're doing here in Rotterdam and Delft is unique. Thanks to the Flagship, we can demonstrate the value of technology to both Dutch and international healthcare. In the first few years, we've already taken significant steps to improve home-based care. That's very motivating. Helping to advance healthcare step by step—that's what gets me out of bed every day.'

Richard Goossens is in a conversation.

Professor R.H.M. (Richard) Goossens, Professor of Physical Ergonomics at TU Delft.

What is TU Delft's role in this Flagship?

'From a technological perspective, we focus on two aspects. On the one hand, there's the design side, where the user is central—this is also my field of expertise. The other aspect is more about engineering: the technology you can use to measure someone's medical condition, such as sensor technology or chips that can extract information from a drop of blood or urine. These can then be linked to apps.'

Can you name some examples of projects?

'One project I find particularly exciting is PregnaDigit. In this project, high-risk pregnant women are monitored at home. Using measurement equipment developed for the project, they can track their own blood pressure or create an ECG of their unborn baby. As long as these measurements remain within safe and responsible limits, they don't need to visit the hospital for check-ups. A similar project is running for patients with pulmonary fibrosis. With a device they exhale into, patients can monitor whether their lung function is deteriorating and whether they need medication. Both projects have already saved hundreds of hours of hospital visits. If you calculate the cost savings and the potential for scaling, you're looking at millions of euros in healthcare savings.

In another project, we're exploring the use of an avatar—a virtual assistant. How do patients respond to it? What preferences do they have regarding its appearance? And how can we ensure the information it provides is reliable? The great thing about this Flagship is that we don't just research these things—we also test them. We're a breeding ground for innovative technology, with Erasmus MC as our platform.'

Waiting room with white chairs, a table, and medical posters.

Does this mean the physical consulting room will eventually dissapear?

'I expect it will. I think that, in the long run, hospitals will primarily be places for surgeries and acute care. The healthcare system will undergo a major transformation, and the relationship between healthcare providers and patients will look very different. Through the smart use of technology, patients will have much more access to their own medical data and will be able to do more themselves. The doctor will oversee this from a distance, equipped with the most up-to-date medical knowledge. In twenty years, we'll look back at our current system as functional but inefficient.'

How long will it take before this becomes reality?

'Some innovations are already a reality, such as the monitoring of pregnant women and patients with pulmonary fibrosis. Sometimes, reality catches up with us. When we started the Flagship, we discussed a system where conversations between a doctor and a patient could be recorded using intelligent recording devices and documented in a report. The big advantage is that the doctor doesn't have to constantly look at a screen but can focus on the conversation. If you take this further, you could even use keywords from the report to automatically place an order with the pharmacy. Due to all the developments in AI and tools like ChatGPT, this is already being applied in some places.

The major challenge lies in changing the healthcare system as a whole. DRIFT—a research institute at EUR specialising in transition science—has beautifully demonstrated that we are on the eve of a transition in healthcare. What you often see in a system on the verge of collapse is that all kinds of repairs are made to things that no longer work. This is currently happening in healthcare. People are working on partial solutions, while everyone knows that radical change is needed. With our multidisciplinary approach, we can give this transition the necessary direction.'

Professor Kees Ahaus looks towards the camera. Kay Duit kijkt smiles towards the camera.

Professor CTB (Kees) Ahaus, Professor of Health Services Management & Organisation at Erasmus School of Health Policy & Management. (left)

Kay Duit, PhD student in Health Services Management & Organisation at Erasmus School of Health Policy & Management. (right)

What are you researching at EUR as part of this Flagship?

Kees: 'We want to map out how costs change when part of the care is shifted to the home, what cost benefits this creates, and what alternative financing models exist. Currently, healthcare financing often operates on a fee-for-service (FFS) basis. This means a health insurer pays a healthcare provider for the care delivered to a patient in the hospital. If a larger portion of care takes place at home, a hospital may incur lower costs but also generate less revenue. What does this mean? What alternative financing models are there? And how do we involve health insurers in this? For innovations in healthcare to succeed, it's crucial that there is an incentive for all parties to embrace change.'

A patient's heart rate is being measured.

How do you create such a cost overview?

Kay: 'One of the care pathways we're looking at is acute obstetric care, as part of the PregnaDigit project. Using a methodology called time-driven activity-based costing, we compare the costs of hospitalising a woman with a complex pregnancy versus her measuring her own blood pressure and creating an ECG of her unborn baby at home. For example, hospital admission involves higher costs for staff and bed occupancy, but home measurement devices also come with costs. In a model, I examine all these costs in great detail. Ultimately, this results in a difference. I hope to have the cost overview for acute obstetric care at Erasmus MC and home monitoring ready by the end of this year.

In another project, SUITS, which focuses on home monitoring for pulmonary fibrosis, we take an even broader approach and include societal costs. If someone has to go to the hospital, it means they may temporarily be unable to work. Often, a partner or family member also has to take time off to accompany them, which incurs additional costs. When you include these costs, you get a different model than if you only look at the costs for the healthcare provider. There are, therefore, multiple ways to assess the costs of digital interventions or shifting care to the home.'

You're also looking at alternative financing models. How do you ensure that more home-based care is beneficial for all parties?

Kees: 'One possibility is to move away from fee-for-service and look at shared savings. In this financing model, healthcare providers and insurers agree to share the cost savings. Instead of focusing on lost revenue, you look at the cost savings achieved by moving care from the hospital to the home. You essentially compensate the hospital for the financial disadvantage over a certain period. This approach shifts the incentive from volume-based (the more care, the more revenue) to value-based, where the interests of the hospital, insurer, patient, and society are central—both in the short and long term.'

Kay: 'The shared savings model also gives hospitals an incentive to test or research an innovation in the first place. With the current financing models, they often back out even before or during the pilot phase because they fear lower revenue or added complexity. Yet, an innovation may prove beneficial in the long run. If there's no room to test an innovation, it will never make its way into standard practice. It's also important to first determine whether an innovation replaces existing care or adds to it. In the latter case, it almost always becomes more expensive—and that’s not what we want.'

What are the main challenges?

Kay: 'One of the biggest challenges is convincing parties that we need new financing methods. Change almost always meets resistance. Healthcare has traditionally been slow to adopt innovations, especially when it comes to introducing new treatments and medications. This is understandable, as every aspect must be thoroughly tested before implementation. However, it's unfortunate that this conservative approach has also seeped into other areas of healthcare, such as financing models. If there were more room for innovation there, it could yield benefits much faster. I would love for our research to provide a scientific foundation that enables real-world changes to take place.'

Convergence Health & Technology

Convergence Health & Technology

Erasmus MC, TU Delft, and Erasmus University Rotterdam (EUR) work closely together in a leading national partnership: Convergence Health & Technology. We uniquely integrate technological, medical, and social sciences to address the greatest healthcare challenges of the 21st century—both in the Netherlands and internationally. We bring together open, transdisciplinary teams with a strong focus on implementation. This accelerates innovation, leads to tangible market outcomes, and generates new knowledge that continuously transforms healthcare.

More information

Would you like more information? Please contact Fien Bosman, Science Communications Officer for Health & Technology, at f.j.bosman@tudelft.nl.

Related content
Using technology, EUR, Erasmus MC, TU Delft and Rijndam are working to develop programmes, cost-effective solutions for home-based rehabilitation and monitoring
A woman is doing rehabilitation on an exercise bike.
Related links
Read all about the Convergence partnership here
Looking for more information about the Health & Technology domain within Convergence? Take a look here!

Compare @count study programme

  • @title

    • Duration: @duration
Compare study programmes